Related Experiment Video
Updated: Jul 20, 2026

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies
K Janssen1, T G Hofmann, D A Jans
1Institute of Molecular Medicine, Heinrich-Heine-University, Düsseldorf, Germany.
Abstract:
Apoptin, a protein of the chicken anemia virus (CAV), represents a novel potential anticancer therapeutic, because it induces apoptotic death specifically in tumor but not normal cells. The cellular localization appears to be crucial for apoptin's selective toxicity. In normal cells apoptin remains in the cytoplasm, whereas in transformed cells it migrates into the nucleus and kills the cell. However, the manner by which apoptin is able to distinguish between tumor and normal cells is unknown. Here, we report for the first time that apoptin interacts directly with the promyelocytic leukemia protein (PML) in tumor cells and accumulates in PML nuclear bodies (NBs), which are involved in apoptosis induction and viral replication. We also demonstrate that apoptin is sumoylated and that a sumoylation-deficient apoptin mutant is no longer recruited to PML-NBs, but localizes in the nuclear matrix. This mutant fails to bind PML, but can still induce apoptosis as efficiently as wild-type apoptin. Moreover, apoptin kills also PML-/- cells and promyelocytic leukemia cells with defective PML expression. Our results therefore suggest that apoptin kills tumor cells independently of PML and sumoylation, however, the interaction of apoptin with PML and small ubiquitin-like modifier (SUMO) proteins might be relevant for CAV replication.
Insights
Chicken anemia virus (CAV) apoptin protein shows potential as an anticancer therapeutic by inducing tumor cell death. It selectively targets cancer cells, independent of promyelocytic leukemia (PML) protein interactions, suggesting a novel cancer treatment pathway.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Apoptin, derived from chicken anemia virus (CAV), exhibits selective toxicity towards tumor cells, inducing apoptosis.
- The precise mechanism of apoptin's tumor cell selectivity and its cellular localization are not fully understood.
Purpose of the Study:
- To investigate the interaction of apoptin with promyelocytic leukemia (PML) protein and PML nuclear bodies (NBs).
- To elucidate the role of apoptin sumoylation in its cellular localization and tumoricidal activity.
- To determine if PML is essential for apoptin-mediated tumor cell killing.
Main Methods:
- Co-immunoprecipitation assays to detect apoptin-PML interaction.
- Confocal microscopy to visualize cellular localization of apoptin and PML NBs.
- Analysis of sumoylation-deficient apoptin mutants.
- Apoptosis assays in various cell lines, including PML-deficient cells.
Main Results:
- Apoptin directly interacts with PML and accumulates in PML NBs in tumor cells.
- Apoptin undergoes sumoylation, and this modification is crucial for its recruitment to PML NBs.
- A sumoylation-deficient apoptin mutant localizes to the nuclear matrix, fails to bind PML, but retains full apoptotic activity.
- Apoptin effectively kills tumor cells irrespective of PML expression levels or functional PML NBs.
Conclusions:
- Apoptin induces tumor cell apoptosis independently of PML and sumoylation.
- The interaction between apoptin, PML, and SUMO proteins may be significant for CAV replication, but not for apoptin's anticancer efficacy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Regulation of Nuclear Protein Sorting
The Extrinsic Apoptotic Pathway
Apoptosis
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

